Accelerating Life Sciences Decisions with Real World Data

Life sciences teams have more real‑world data than ever, but turning it into decision‑grade answers is still slow—spread across disconnected sources, heavy manual work, and analysis cycles that don’t match the pace of the market.  Ario exists to remove this gap.

ArioGPT is an AI‑native platform that brings claims, EHR, labs, and outcomes together, then automates the work to turn that information into clear next steps to act on these insights. It’s tailor-fit for medical affairs, HEOR, and other teams to quickly identify responder patterns, determine real‑world experience, and quantify market impact.  This enables organizations to move from “What are we seeing?” to “What should we do next?” with speed, scale, and confidence.

ArioGPT v1.3 on the Horizon

We’re excited to share that ArioGPT version 1.3 is scheduled for release next quarter. This update is focused on making repetitive real‑world analysis algorithms scalable. We’re adding the ability for teams to easily integrate new data sets with our new “dropbox” import function.  

Further, users can now collaborate on cohort queries, branch them for additional analyses, and even duplicate them and compare statistics between versions. Users can now quickly visualize the dynamic changes over time and identify clear trends and patterns.

We’ll be offering early access previews to select partners ahead of the release and will share additional details as we get closer to launch. If you’d like to be included in the v1.3 preview group, click on the link below.